Cambridge, MA, May 16, 2012 (GLOBE NEWSWIRE) -- LaVoie Strategic Communications, Inc. "LaVoie Group" announced today the opening of a new office in Cambridge, Massachusetts. Located at 201 Broadway (Kendall Sq.) in the heart of the biotechnology community, the office will support the Agency's growing list of life science clients. The new location will also allow the firm's talent to participate in the rich community consisting of the world's leading biopharmaceutical companies, research institutes and surrounding hospitals.
LaVoie Group provides global life science companies with strategic consulting and integrated communications programs in Investor Relations, Public Relations, Corporate and Marketing Communications. The Agency has a specialized focus on understanding the life science markets, and their experienced talent designs and implements targeted, personalized services tailored to clients' business and marketing objectives.
"Massachusetts is globally recognized as the leader in biopharmaceutical and healthcare companies," said Donna LaVoie, President and CEO of LaVoie Group. "To be in the center of Cambridge's thriving life sciences cluster was a fundamental aspect in the decision to expand offices. The LG team looks forward to becoming a part of this rich community and the benefits it will bring."
"Cambridge allows us to enhance the representation of and communication with our clients," stated Cindy Miller, Vice President Product Marketing and Communications. "We are servicing a number of businesses in the Kendall Square and Greater Boston Area, and we want to be more accessible to them."
About LaVoie Group
LaVoie Group partners with leading life sciences brands to build their companies, attract capital, and reach key stakeholders through integrated communications and marketing. The firm provides strategy consulting and integrated communications programs designed to properly position, create visibility and drive value.
Our clients are industry leaders in life sciences and pharmaceuticals and governments, including, Aegerion Pharmaceuticals, AliveCor, Vertex Pharmaceuticals, Radius Health, Novadaq Technologies, Oympus Biotech, the Commonwealth of Massachusetts, MPM Capital, Hydra Biosciences and Hepregen Corporation.
LaVoie Group is ranked by O'Dwyer's PR Report as one of the leading independent healthcare PR firms in the U.S. and has been honored for the past four years by the LACP for best agency awards, including the 2011 "Best Small Agency".